Biotech

All Articles

James Wilson leaving behind Penn to release pair of brand-new biotechs

.After much more than three decades, gene therapy trailblazer James Wilson M.D., Ph.D., is leaving t...

3 biotechs try to trump the summer season warmth through shedding staff

.As biotechs seek to turn a new webpage in August, at least three business have dropped team in trie...

venBio lifts $528M for 5th life scientific researches VC fund

.Professional financial backing organization venBio has lifted another half a billion bucks to acqui...

Otsuka pays out $800M for Jnana as well as its own clinical-stage PKU medication

.Otsuka Drug has actually picked up Boston-based Jnana Therapies for $800 million so the Japanese bi...

FibroGen lays off 75% people team as property flunks 2 even more trials

.FibroGen is significantly restructuring its own company, laying off 75% of its own U.S. staff and q...

Tracon wane full weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has actually determined to relax functions weeks after an injectable invulne...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on failed epilepsy drug, proclaims FDA manage

.Our team already understand that Takeda is wanting to discover a road to the FDA for epilepsy medic...

VBI Vaccines files for insolvency, looks for asset sale

.Immunology biotech VBI Vaccinations is drifting dangerously near the point of no return, with strat...

Celldex anti-cKIT antibody decrease colonies in an additional stage 2 research

.It is actually not easy to muscle in on an area as reasonable as immunology, however Celldex Therap...